Amresh Kumar - 06 May 2024 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Role
VP Clinical Operations
Signature
/s/ Carrie D'Andrea
Issuer symbol
GRCE
Transactions as of
06 May 2024
Net transactions value
$0
Form type
4
Filing time
08 May 2024, 19:19:20 UTC
Previous filing
18 Jul 2023
Next filing
16 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +19,740 $0.000000 19,740 06 May 2024 Class A Common Shares 19,740 $2.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.